332 related articles for article (PubMed ID: 1911826)
21. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the drug retention and pharmacokinetic properties of liposomal nanoparticles containing dihydrosphingomyelin.
Johnston MJ; Semple SC; Klimuk SK; Ansell S; Maurer N; Cullis PR
Biochim Biophys Acta; 2007 May; 1768(5):1121-7. PubMed ID: 17321495
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration.
Romberg B; Oussoren C; Snel CJ; Carstens MG; Hennink WE; Storm G
Biochim Biophys Acta; 2007 Mar; 1768(3):737-43. PubMed ID: 17223070
[TBL] [Abstract][Full Text] [Related]
24. Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.
Duan Y; Wei L; Petryk J; Ruddy TD
Int J Nanomedicine; 2016; 11():5697-5708. PubMed ID: 27843312
[TBL] [Abstract][Full Text] [Related]
25. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
[TBL] [Abstract][Full Text] [Related]
26. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).
Maruyama K; Yuda T; Okamoto A; Kojima S; Suginaka A; Iwatsuru M
Biochim Biophys Acta; 1992 Sep; 1128(1):44-9. PubMed ID: 1390877
[TBL] [Abstract][Full Text] [Related]
27. Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs.
Gabizon AA; Barenholz Y; Bialer M
Pharm Res; 1993 May; 10(5):703-8. PubMed ID: 8321835
[TBL] [Abstract][Full Text] [Related]
28. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice.
Deol P; Khuller GK
Biochim Biophys Acta; 1997 Mar; 1334(2-3):161-72. PubMed ID: 9101710
[TBL] [Abstract][Full Text] [Related]
29. Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes.
Woodle MC; Matthay KK; Newman MS; Hidayat JE; Collins LR; Redemann C; Martin FJ; Papahadjopoulos D
Biochim Biophys Acta; 1992 Apr; 1105(2):193-200. PubMed ID: 1586658
[TBL] [Abstract][Full Text] [Related]
30. The presence of GM1 in liposomes with entrapped doxorubicin does not prevent RES blockade.
Parr MJ; Bally MB; Cullis PR
Biochim Biophys Acta; 1993 Jun; 1168(2):249-52. PubMed ID: 8504161
[TBL] [Abstract][Full Text] [Related]
31. The effect of stealth liposomes on pharmacokinetics, tissue distribution and anti-tumor activity of oridonin.
Wang C; Wei Y; Yu L; Zhang L
PDA J Pharm Sci Technol; 2009; 63(5):409-16. PubMed ID: 20158047
[TBL] [Abstract][Full Text] [Related]
32. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits.
Awasthi VD; Garcia D; Goins BA; Phillips WT
Int J Pharm; 2003 Mar; 253(1-2):121-32. PubMed ID: 12593943
[TBL] [Abstract][Full Text] [Related]
33. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
Allen TM; Everest JM
J Pharmacol Exp Ther; 1983 Aug; 226(2):539-44. PubMed ID: 6875864
[TBL] [Abstract][Full Text] [Related]
34. Liposome clearance from blood: different animal species have different mechanisms.
Liu D; Hu Q; Song YK
Biochim Biophys Acta; 1995 Dec; 1240(2):277-84. PubMed ID: 8541299
[TBL] [Abstract][Full Text] [Related]
35. Targeted and sustained drug delivery using PEGylated galactosylated liposomes.
Managit C; Kawakami S; Nishikawa M; Yamashita F; Hashida M
Int J Pharm; 2003 Nov; 266(1-2):77-84. PubMed ID: 14559396
[TBL] [Abstract][Full Text] [Related]
36. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice.
Huang SK; Lee KD; Hong K; Friend DS; Papahadjopoulos D
Cancer Res; 1992 Oct; 52(19):5135-43. PubMed ID: 1394121
[TBL] [Abstract][Full Text] [Related]
37. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times.
Gabizon A; Shiota R; Papahadjopoulos D
J Natl Cancer Inst; 1989 Oct; 81(19):1484-8. PubMed ID: 2778836
[TBL] [Abstract][Full Text] [Related]
39. Serum independent liposome uptake by mouse liver.
Liu F; Liu D
Biochim Biophys Acta; 1996 Jan; 1278(1):5-11. PubMed ID: 8611606
[TBL] [Abstract][Full Text] [Related]
40. Liposomes for the sustained drug release in vivo.
Blume G; Cevc G
Biochim Biophys Acta; 1990 Nov; 1029(1):91-7. PubMed ID: 2223816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
